Comparing two methods for obtaining lung cancer tissue samples
Official title: A Multicenter Randomized Trial of EBUS-TBNA Versus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing
Run by Vanderbilt-Ingram Cancer Center · NCT06105801 · Data updated 2026-11-12
This study is testing which method, cryobiopsy or EBUS-TBNA, is better at getting enough lung cancer tissue samples for testing in patients.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Vanderbilt-Ingram Cancer Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | September 13, 2024 |
| Main results expected | October 31, 2027 |
| Study ends | October 31, 2028 |
| Registry record updated | February 2, 2026 |
| Trial ID | NCT06105801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with suspected malignant lung lesions that are amenable to biopsy and have shown malignant cells on rapid on-site cytological evaluation.
✕Probably not a fit
Patients who are under 18 years old, pregnant, or whose lesions are deemed unsafe for biopsy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multi-center clinical trial evaluates the effectiveness of transbronchial mediastinal cryobiopsy compared to endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA) in acquiring sufficient tissue for molecular analysis in lung cancer patients. Participants will be randomized to receive either the standard EBUS-TBNA or the cryobiopsy method during their bronchoscopic biopsy procedure. The study aims to determine which method yields a higher proportion of adequate samples for next-generation sequencing and assesses safety endpoints related to the procedures.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of lung cancer diagnoses and treatment planning through improved tissue sampling techniques.
How similar studies have gone: Other studies have explored similar biopsy techniques, but this specific comparison of cryobiopsy and EBUS-TBNA for next-generation sequencing adequacy is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Lesions on PET or CT concerning for primary or metastatic malignancy that are amenable to biopsy by linear EBUS * Malignant cells present on rapid on-site cytological evaluation (ROSE) Exclusion Criteria: * Patient is known to be less than 18 years old * Patient is known to be pregnant * Patient is known to be a prisoner * Operator deems lesion is not safe to biopsy
Where it's running
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Fabien Maldonado, MD — Vanderbilt University/Ingram Cancer Center
- Study coordinator: Vanderbilt-Ingram Services for Timely Access
- Email: cip@vumc.org
- Phone: 800-811-8480
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.